2009
DOI: 10.1016/j.brainres.2009.05.027
|View full text |Cite
|
Sign up to set email alerts
|

Adenosine A1 receptors presynaptically modulate excitatory synaptic input onto subiculum neurons

Abstract: Adenosine is an endogenous neuromodulator previously shown to suppress synaptic transmission and membrane excitability in the CNS. In this study we have determined the actions of adenosine on excitatory synaptic transmission in the subiculum, the main output area for the hippocampus. Adenosine (10 μM) reversibly inhibited excitatory post synaptic currents (EPSCs) recorded from subiculum neurons. These actions were mimicked by the A 1 receptor specific agonist, N 6 -cyclopentyl-adenosine (CPA, 10 nM) and blocke… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
7
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 41 publications
1
7
0
Order By: Relevance
“…These receptors are localized on presynaptic terminals and modulate the release of neurotransmitters, including glutamate and GABA (Dunwiddie and Masino, 2001). We assessed whether Tat impairs A 1 AR function by monitoring EPSC amplitude in the presence of a selective A 1 AR agonist N 6 -cyclopentyladenosine (CPA; 10 nM; Hargus et al, 2009;Gonçalves et al, 2015) and partial agonist capadenoson (30 nM; Albrecht-Kupper et al, 2012). CPA inhibited EPSC amplitude by 74 6 5% in control cultures and by 77 6 5% in cultures treated with 50 ng/ml Tat for 24 h (Fig.…”
Section: Tat Does Not Affect Adenosine a 1 Receptor (A 1 Ar)mediated Presynaptic Inhibitionmentioning
confidence: 99%
“…These receptors are localized on presynaptic terminals and modulate the release of neurotransmitters, including glutamate and GABA (Dunwiddie and Masino, 2001). We assessed whether Tat impairs A 1 AR function by monitoring EPSC amplitude in the presence of a selective A 1 AR agonist N 6 -cyclopentyladenosine (CPA; 10 nM; Hargus et al, 2009;Gonçalves et al, 2015) and partial agonist capadenoson (30 nM; Albrecht-Kupper et al, 2012). CPA inhibited EPSC amplitude by 74 6 5% in control cultures and by 77 6 5% in cultures treated with 50 ng/ml Tat for 24 h (Fig.…”
Section: Tat Does Not Affect Adenosine a 1 Receptor (A 1 Ar)mediated Presynaptic Inhibitionmentioning
confidence: 99%
“…The effect of heightened sleepiness as a result of elevated adenosine levels can be reproduced by pharmacologically increasing adenosine (Porkka-Heiskanen 1997). Increased adenosine due to sleep deprivation contributes to activation of the adenosine A1 receptor, which inhibits synaptic transmission through attenuation of activity from neighboring excitatory neurons (Brundege and Dunwiddie 1996;Haas and Selbach 2000;Hargus et al 2009). Activation of the A1 receptor also inhibits cAMP signaling through G i protein coupling, intersecting with another disrupted pathway (Haas and Selbach 2000;Fredholm et al 2005).…”
Section: Adenosine and Astrocytesmentioning
confidence: 99%
“…Activation of the adenosinergic system by adenosine is known to exert depressant effects on neuronal transmission within the brain (Dunwiddie & Haas, 1985; Moore et al., 2003; Hargus et al., 2009). Four adenosine receptors have been identified to date (A 1 , A 2A , A 2B , and A 3 ); however, within the central nervous system (CNS), adenosine A 1 and A 2A receptors are most widely expressed and it is the A 1 subtype that has been primarily implicated in neuroprotection (Wardas, 2002).…”
mentioning
confidence: 99%